Clinical trials
Active, not recruiting Urinary Bladder Neoplasms trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 5 |
| Merck Sharp & Dohme LLC | 4 |
| Janssen Research & Development, LLC | 3 |
| BicycleTx Limited | 2 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| IDEAYA Biosciences | 1 |
| Pfizer | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 18 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Carcinoma, Transitional Cell | 2 |
| Ovarian Neoplasms | 2 |
| Stomach Neoplasms | 2 |
| Biliary Tract Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Colorectal Neoplasms | 1 |
| Endometrial Neoplasms | 1 |
| Gastrointestinal Neoplasms | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.